Filing Details
- Accession Number:
- 0000950170-25-054819
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-16 17:00:04
- Reporting Period:
- 2025-04-15
- Filing Date:
- 2025-04-16
- Accepted Time:
- 2025-04-16 17:00:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 2012593 | Rapport Therapeutics Inc. | RAPP | Pharmaceutical Preparations (2834) | 880724208 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2022087 | David Bredt | Rapport Therapeutics, Inc. 1325 Boylston Street, Suite 401 Boston MA 02215 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-04-15 | 8,500 | $9.57 | 460,642 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.18 to $10.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Billionaire Hedge Funds
